BioSynthema

BioSynthema Discovers and Develops Unique Drugs Targeting Overexpressed Cell Surface Receptors in Cancer Cells. This technology uses diagnostic imaging methods to make specific tumors highly visible, enabling earlier and more accurate diagnosis. The technology is also applicable to cancer treatment. BioSynthema is currently developing compounds that can provide new and effective products to the market for diagnosing and treating neuroendocrine tumors.